Literature DB >> 16140790

Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans.

Oscar Norbeck1, Adiba Isa, Christoph Pöhlmann, Kristina Broliden, Victoria Kasprowicz, Paul Bowness, Paul Klenerman, Thomas Tolfvenstam.   

Abstract

Murine models have suggested that CD8+ T-cell responses peak early in acute viral infections and are not sustained, but no evidence for humans has been available. To address this, we longitudinally analyzed the CD8+ T-cell response to human parvovirus B19 in acutely infected individuals. We observed striking CD8+ T-cell responses, which were sustained or even increased over many months after the resolution of acute disease, indicating that CD8+ T cells may play a prominent role in the control of parvovirus B19 and other acute viral infections of humans, including potentially those generated by live vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140790      PMCID: PMC1212640          DOI: 10.1128/JVI.79.18.12117-12121.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis.

Authors:  M E Sheehy; A B McDermott; S N Furlan; P Klenerman; D F Nixon
Journal:  J Immunol Methods       Date:  2001-03-01       Impact factor: 2.303

2.  Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.

Authors:  K Kuzushima; N Hayashi; H Kimura; T Tsurumi
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

3.  Population analysis of antiviral T cell responses using MHC class I-peptide tetramers.

Authors:  H Komatsu; S Sierro; A V Cuero; P Klenerman
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

4.  Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals.

Authors:  Erik D Heegaard; Bodil Laub Petersen; Carsten J Heilmann; Allan Hornsleth
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.

Authors:  T Tolfvenstam; A Oxenius; D A Price; B L Shacklett; H M Spiegel; K Hedman; O Norbeck; M Levi; K Olsen; M Kantzanou; D F Nixon; K Broliden; P Klenerman
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19.

Authors:  R Franssila; K Hokynar; K Hedman
Journal:  J Infect Dis       Date:  2001-01-29       Impact factor: 5.226

7.  Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.

Authors:  Georg M Lauer; Kei Ouchi; Raymond T Chung; Tam N Nguyen; Cheryl L Day; Deborah R Purkis; Markus Reiser; Arthur Y Kim; Michaela Lucas; Paul Klenerman; Bruce D Walker
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.

Authors:  Rauli Franssila; Klaus Hedman
Journal:  Vaccine       Date:  2004-09-09       Impact factor: 3.641

9.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

10.  Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.

Authors:  Andrew D Hislop; Nicola E Annels; Nancy H Gudgeon; Alison M Leese; Alan B Rickinson
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

View more
  16 in total

1.  Selfness-nonselfness in designing an anti-B19 erythrovirus vaccine.

Authors:  Candida Fasano; Darja Kanduc
Journal:  Self Nonself       Date:  2011-04-01

2.  Dynamics of killer T cell inflation in viral infections.

Authors:  Dominik Wodarz; Sophie Sierro; Paul Klenerman
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

Review 3.  Vaccine Design Informed by Virus-Induced Immunity.

Authors:  Rhiannon R Penkert; Jane S Hankins; Neal S Young; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-05-05       Impact factor: 2.257

4.  Cytokine responses in acute and persistent human parvovirus B19 infection.

Authors:  A Isa; A Lundqvist; A Lindblom; T Tolfvenstam; K Broliden
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

Review 5.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  Prolonged Evolution of Virus-Specific Memory T Cell Immunity after Severe Avian Influenza A (H7N9) Virus Infection.

Authors:  Min Zhao; Junbo Chen; Shuguang Tan; Tao Dong; Hui Jiang; Jiandong Zheng; Chuansong Quan; Qiaohong Liao; Hangjie Zhang; Xiling Wang; Qianli Wang; Yuhai Bi; Fengfeng Liu; Luzhao Feng; Peter W Horby; Paul Klenerman; George F Gao; William J Liu; Hongjie Yu
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

7.  High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.

Authors:  Ruth Simmons; Colin Sharp; Stuart Sims; Henrik Kloverpris; Philip Goulder; Peter Simmonds; Paul Bowness; Paul Klenerman
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

8.  Prolonged activation of virus-specific CD8+T cells after acute B19 infection.

Authors:  Adiba Isa; Victoria Kasprowicz; Oscar Norbeck; Andrew Loughry; Katie Jeffery; Kristina Broliden; Paul Klenerman; Thomas Tolfvenstam; Paul Bowness
Journal:  PLoS Med       Date:  2005-11-01       Impact factor: 11.069

9.  Diverse IgG subclass responses to adeno-associated virus infection and vector administration.

Authors:  Samuel L Murphy; Hojun Li; Federico Mingozzi; Denise E Sabatino; Daniel J Hui; Shyrie A Edmonson; Katherine A High
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327

10.  Evolution of CD8+ T cell responses after acute PARV4 infection.

Authors:  Ruth Simmons; Colin Sharp; Jordana Levine; Paul Bowness; Peter Simmonds; Andrea Cox; Paul Klenerman
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.